Monday, December 23, 2024
- Advertisement -spot_img

TAG

drug manufacturer

Catalent CEO to remain in charge of contract drugmaker after Novo Holdings’ buyout

(Reuters) - Catalent president and CEO Alessandro Maselli said on Monday he will stay on as the contract drugmaker's chief after it is acquired...

Catalent CEO to remain in charge of contract drugmaker after Novo Holdings’ buyout

(Reuters) - Catalent president and CEO Alessandro Maselli said on Monday he will stay on as the contract drugmaker's chief after it is acquired...

Latest news

- Advertisement -spot_img